Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study (Q43759412)

26 November 2017

title

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study (English)

1 reference

26 November 2017

1 reference

2

Uri Tabori

0 references

David Malkin

9

object named as

David Malkin

0 references

author name string

Anita Villani

1

1 reference

26 November 2017

Joshua Schiffman

3

1 reference

26 November 2017

Adam Shlien

4

1 reference

26 November 2017

Joseph Beyene

5

1 reference

26 November 2017

Harriet Druker

6

1 reference

26 November 2017

Ana Novokmet

7

1 reference

26 November 2017

Jonathan Finlay

8

1 reference

26 November 2017

publication date

19 May 2011

1 reference

Lancet Oncology Commission

26 November 2017

published in

1 reference

26 November 2017

volume

12

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

559-567

1 reference

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Inherited cancer in children: practical/ethical problems and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Multiple primary cancers in families with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Advances in magnetic resonance imaging of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Clinical review: Adrenocortical carcinoma: clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

An application of methods for clustered binary responses to a cardiovascular study with small sample size.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Identification and management of inherited cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Ethical issues with genetic testing in pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Childhood predictive genetic testing for Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Inherited cancer susceptibility syndromes in paediatric practice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Guidelines for genetic testing of healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Germline TP53 mutations and Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Fibroblasts from Li-Fraumeni patients are resistant to low dose-rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

p53 and disease: when the guardian angel fails

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970119-X

7 January 2021

10.1016/S1470-2045(11)70119-X

Identifiers

DOI

1 reference

release_hu3mr3jn3vcgjkoidmsthu6t4q

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hu3mr3jn3vcgjkoidmsthu6t4q

24 November 2022

mapped directly with Wikidata item

1 reference